Corneal Edema - Epidemiology Forecast - 2034

Key Highlights

• The diagnosed prevalent cases of corneal edema across the 7MM experienced a notable increase starting from 2022, and this trend is expected to persist until 2034. This escalating pattern indicates a mounting burden of corneal edema on healthcare systems, emphasizing the critical need for implementing effective management strategies and interventions to mitigate the impact of this condition.
• The 2022 analysis underscored dystrophic causes as the predominant contributors to diagnosed prevalent cases of corneal edema in the 7MM, yet anticipates dynamic shifts in etiologies over time, encompassing mechanical and inflammatory causes as well.

The “Corneal Edema - Epidemiology - 2034” report delivers an in-depth understanding of the Corneal Edema, historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2020-2034

Disease Understanding and Diagnostic Algorithm

Corneal Edema Overview

Corneal edema, marked by the swelling of the cornea due to fluid accumulation, can stem from diverse causes like trauma, inflammation, or underlying conditions such as Fuchs' dystrophy. Symptoms include blurred vision and light sensitivity. Pathologically, it involves alterations in the kidney's glomeruli, affecting filtration and leading to protein leakage in urine, notably albumin. Treatment decisions hinge on factors like edema severity, underlying causes, patient symptoms, and potential risks and benefits of interventions.

Corneal Edema Diagnosis

Diagnosis of corneal edema involves a comprehensive eye examination, including slit-lamp biomicroscopy, corneal pachymetry, and evaluation of visual acuity. Early detection and appropriate management are crucial in preventing complications and preserving vision.

Corneal Edema Epidemiology

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by the Total Diagnosed Prevalent Cases of Corneal Edema and the Etiology-specific Diagnosed Prevalent Cases of Corneal Edema in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2020 to 2034.

• In 2022, the diagnosed prevalent population of Corneal Edema in the US was around 1 million which is expected to increase by 2034.
• The 2022 estimates indicate that the primary cause of diagnosed prevalent cases of corneal edema in the US was attributed to dystrophic causes, with the highest number of cases. It is anticipated that there will be shifts in these cases over the course of the study period.

KOL Views

To gaze into the epidemiology insights of the real world, we take KOLs and SMEs’ opinions working in the domain through primary research to fill the data gaps and validate the secondary research. Industry Experts were contacted for insights on Corneal Edema evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, along with challenges related to accessibility, including KOL from University of Utah Hospital; Department of Ophthalmology, Columbia University, New York; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, Department of Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota; and others.

The analysts connected with 50+ KOLs to gather insights; however, interviews were conducted with 15+ KOLs in the 7MM. Their opinion helps understand and validate current disease prevalence, gender involved with the disease, diagnosis rate, and diagnostic criteria.

Scope of the Report

• The report covers a segment of key events, an executive summary, descriptive overview of Corneal Edema, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, disease progression, and guidelines.
• The report provides an edge for understanding trends, expert insights/ KOL views, and patient journeys in the 7MM.
• A detailed review of current challenges in establishing the diagnosis.

Corneal Edema Report Insights

• Patient Population
• Country-wise Epidemiology Distribution
• Total Diagnosed Prevalent Cases of Corneal Edema
• Type-specific Diagnosed Prevalent Cases of Corneal Edema

Corneal Edema Report Key Strengths

• 12 years Forecast
• The 7MM Coverage
• Corneal Edema Epidemiology Segmentation

Key Questions

Epidemiology Insights

• What are the disease risks, burdens, and unmet needs of Corneal Edema? What will be the growth opportunities across the 7MM concerning the patient population of Corneal Edema?
• What is the historical and forecasted Corneal Edema patient pool in the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan?
• Why do only limited patients appear for diagnosis?
• Which country is more prevalent for Corneal Edema and why?
• What factors are affecting the diagnosis of the indication?

Reasons to Buy

• Insights on patient burden/disease, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand the corneal edema prevalence cases in varying geographies over the coming years.
• To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis options.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.

Frequently Asked Questions

1. What is the forecast period covered in the report?

The Corneal Edema Epidemiology report for the 7MM covers the forecast period from 2023 to 2034, providing a projection of epidemiology dynamics and trends during this timeframe.

2. How is epidemiological data collected and analyzed for forecasting purposes?

Epidemiological data is collected through surveys, clinical studies, health records, and other sources. It is then analyzed to calculate disease rates, identify trends, and project future disease burdens using mathematical models.

3. Out of all 7MM countries, which country had the highest population of Corneal Edema cases in 2022?

The highest cases of Corneal Edema were found in the US among the 7MM in 2022.